Compare BRC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRC | PLSE |
|---|---|---|
| Founded | 1914 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.6B |
| IPO Year | 2005 | 2015 |
| Metric | BRC | PLSE |
|---|---|---|
| Price | $85.37 | $55.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $1.20 | ★ $22.00 |
| AVG Volume (30 Days) | 172.3K | ★ 578.9K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.20% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,144,698,000.00 | N/A |
| Revenue This Year | $7.36 | $840.00 |
| Revenue Next Year | $3.57 | $287.54 |
| P/E Ratio | $23.35 | ★ N/A |
| Revenue Growth | ★ 5.86 | N/A |
| 52 Week Low | $70.57 | $12.56 |
| 52 Week High | $99.29 | $58.90 |
| Indicator | BRC | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 32.60 | 65.31 |
| Support Level | $78.10 | $15.64 |
| Resistance Level | $86.99 | N/A |
| Average True Range (ATR) | 2.65 | 4.08 |
| MACD | -0.65 | -0.25 |
| Stochastic Oscillator | 11.35 | 60.56 |
Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.